Introduction
Obesity as a chronic disease: bridging pathophysiology and epidemiology, discussing full spectrum of obesity related complications and current obesity management practices, as well as what we can do to help people living with obesity
Objectives
•Reinforce the efficacy of Mounjaro for patients with T2D.
•Put the superior efficacy in the context of the appropriate brand patient Julia and why appropriate control of both HbA1c and weight is fundamental early in the disease history.
•Highlight the benefits of tirzepatide 5mg: superior efficacy and no need for long titration.
This Course For :
Physician
( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General practitioner )
Resident / Fellow
( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General practitioner )
Speaker
Dr. Jonathan Rachman
Medical Fellow, Diabetes, Medical Affairs, International Business Unit, Eli Lilly
Dr. Santiago Tofé
Consultant, Dep. of Endocrinology, Uni. Hospital Son Espases, Ass. Professor University Illes Belears
Prof. Melanie Davies
Professor of Diabetes Medicine, NIHR Senior Investigator Emeritus, Diabetes Research Centre, Leicester Diabetes Care Centre, University of Leicester, United Kingdom
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
22 Oct 2025 To 22 Oct 2025 -
07:30 PM To 08:30 PM 
Certificate Available 
Online
- 148
Add to Calendar
10/22/2025 07:30 PM
10/22/2025 08:30 PM
Asia/ Riyadh
Mounjaro in Advancing Care in T2D
Mounjaro in Advancing Care in T2D
https://medicalacademy.org/portal/event/view/2475
